Vision Disorders

Current Status
Not Enrolled
Get Started

Stem Cells and Glaucoma

The article provides an overview of stem cell therapy for the treatment of glaucoma. It explains that stem cells have the ability to differentiate into the cell types that are damaged in glaucoma and can potentially improve vision. The article also highlights the potential benefits of stem cell therapy for glaucoma, including reduced invasiveness, longer-lasting treatment effect, and the ability to reverse vision loss.

Mesenchymal Stem Cells (MSCs) and Cataracts

Mesenchymal stem cells (MSCs) are a type of adult stem cell that have the potential to treat a variety of medical conditions, including cataracts. Cataracts cause the lens of the eye to become cloudy, leading to vision loss and can be a leading cause of blindness worldwide. Theoretically, MSCs can differentiate into lens cells and replace the damaged lens cells in patients with cataracts. Clinical trials are currently underway to test the safety and efficacy of MSCs in humans.

Mesenchymal Stem Cells and Blindness

The article discusses the potential of mesenchymal stem cells (MSCs) for the treatment of blindness. MSCs are a type of adult stem cell that can differentiate into various cell types, including those of the eye. Animal studies have shown promising results, and early clinical trials have reported improvements in vision and tissue repair in patients with eye diseases.

Stem Cells and Diabetic Retinopathy

The article discusses the potential use of mesenchymal stem cells (MSCs) in the treatment of diabetic retinopathy (DR), a leading cause of blindness. MSCs are capable of self-renewal and differentiation into multiple cell types, making them a promising candidate for treating DR. The article explains that recent clinical trials have shown MSC therapy to be safe and effective in improving the symptoms of DR.